SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-012250
Filing Date
2022-03-31
Accepted
2022-03-31 16:06:14
Documents
12
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20001664x2_def14a.htm DEF 14A 1726232
2 logo_footerprothena.jpg GRAPHIC 8773
3 logo_prothenax1.jpg GRAPHIC 22255
4 ny20001664x2_check.jpg GRAPHIC 4907
5 ny20001664x2_committee.jpg GRAPHIC 6386
6 ny20001664x2_member1x1.jpg GRAPHIC 6134
7 ny20001664x2_pc1.jpg GRAPHIC 806323
8 ny20001664x2_pc2.jpg GRAPHIC 798275
9 ny20001664x2_piechart1.jpg GRAPHIC 125704
10 ny20001664x2_skills.jpg GRAPHIC 600579
11 ny20001664x2_x.jpg GRAPHIC 5627
12 sig_yvonnemtchrakian.jpg GRAPHIC 15421
  Complete submission text file 0001140361-22-012250.txt   5031343
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35676 | Film No.: 22792424
SIC: 2834 Pharmaceutical Preparations